HFS
Hantz Financial Services’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.3M | Sell |
64,857
-6,004
| -8% | -$2.43M | 0.43% | 46 |
|
2025
Q1 | $35.3M | Buy |
70,861
+319
| +0.5% | +$159K | 0.62% | 33 |
|
2024
Q4 | $36.7M | Sell |
70,542
-6,211
| -8% | -$3.23M | 0.64% | 32 |
|
2024
Q3 | $47.5M | Buy |
76,753
+1,046
| +1% | +$647K | 0.84% | 20 |
|
2024
Q2 | $41.9M | Sell |
75,707
-2,586
| -3% | -$1.43M | 0.81% | 22 |
|
2024
Q1 | $45.5M | Buy |
78,293
+21,453
| +38% | +$12.5M | 0.89% | 23 |
|
2023
Q4 | $30.2M | Sell |
56,840
-2,575
| -4% | -$1.37M | 0.66% | 32 |
|
2023
Q3 | $30.1M | Buy |
59,415
+864
| +1% | +$437K | 0.76% | 25 |
|
2023
Q2 | $30.5M | Sell |
58,551
-990
| -2% | -$517K | 0.76% | 25 |
|
2023
Q1 | $34.3M | Buy |
59,541
+714
| +1% | +$412K | 0.94% | 19 |
|
2022
Q4 | $32.4M | Buy |
58,827
+37,794
| +180% | +$20.8M | 0.98% | 17 |
|
2022
Q3 | $10.7M | Sell |
21,033
-269
| -1% | -$136K | 0.37% | 78 |
|
2022
Q2 | $11.6M | Sell |
21,302
-192
| -0.9% | -$104K | 0.39% | 73 |
|
2022
Q1 | $12.7M | Sell |
21,494
-725
| -3% | -$428K | 0.37% | 78 |
|
2021
Q4 | $14.8M | Buy |
22,219
+1,014
| +5% | +$677K | 0.43% | 65 |
|
2021
Q3 | $12.1M | Buy |
21,205
+1,712
| +9% | +$978K | 0.4% | 72 |
|
2021
Q2 | $9.83M | Buy |
19,493
+351
| +2% | +$177K | 0.36% | 74 |
|
2021
Q1 | $8.74M | Sell |
19,142
-193
| -1% | -$88.1K | 0.36% | 77 |
|
2020
Q4 | $9.01M | Buy |
19,335
+4
| +0% | +$1.86K | 0.4% | 64 |
|
2020
Q3 | $8.54M | Sell |
19,331
-577
| -3% | -$255K | 0.44% | 56 |
|
2020
Q2 | $7.21M | Sell |
19,908
-45
| -0.2% | -$16.3K | 0.4% | 61 |
|
2020
Q1 | $5.66M | Buy |
+19,953
| New | +$5.66M | 0.39% | 67 |
|